Navigation Links
Mammograms Can Measure How Breast Cancer Drug Is Working: Study
Date:4/23/2013

MONDAY, April 22 (HealthDay News) -- Mammograms can be used to see how well breast cancer patients are responding to treatment with the drug tamoxifen, a new study suggests.

Researchers at the Karolinska Institute in Sweden report that women who saw a 20 percent or more reduction in breast density during tamoxifen treatment had a 50 percent lower risk of dying from breast cancer over an average of 15 years, compared with women who had little or no change in breast tissue density during treatment.

The study uncovered a link between reductions in breast density while on tamoxifen and a lowered risk of death. However, it didn't find a cause-and-effect relationship.

Using mammograms to determine if a patient is responding to tamoxifen can be done at an early stage of treatment, the researchers added.

The Swedish team looked at nearly 1,000 postmenopausal women who had been treated for breast cancer. About half of them had been treated with tamoxifen, according to the study, which was published online April 22 in the Journal of Clinical Oncology.

Tamoxifen is a common hormone-therapy drug typically given over five years to prevent relapse in women who have completed their primary breast cancer treatment. However, there has been no way to assess which patients are most likely to respond to tamoxifen treatment.

These findings suggest a possible method for doing so, the researchers said.

"What's needed is accurate measurement of mammographic density, which isn't currently routine," Per Hall, a professor in the department of medical epidemiology and biostatistics, said in a Karolinska Institute news release. "Measuring changes in density can be a simple and cheap means of assessing the effect of the treatment. If a patient is not responding to tamoxifen, maybe they should be given a different drug."

More information

The U.S. National Cancer Institute has more about breast cancer treatment.

-- Robert Preidt

SOURCE: Karolinska Institute, news release, April 22, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Routine mammograms may result in significant overdiagnosis of invasive breast cancer
2. Here Are the Women Who Need Mammograms in Their 40s: Study
3. No family history not a good reason for women 40-49 to stop yearly screening mammograms
4. Mammograms Beat Thermography for Breast Cancer Detection: Study
5. US mammograms decline after task force recommendation, Mayo Clinic finds
6. Mammograms Have Limited or No Effect on Breast Cancer Deaths: Study
7. Breast Cancer Charity Overstates Value of Mammograms: Researchers
8. Mammograms Do Not Prevent Advanced Breast Cancer, Study Suggests
9. For Older Women, Mammograms Every 2 Years Found as Good as Annual Test
10. Mammograms Every Other Year OK for Women Over 50: Study
11. False-Positive Mammograms Can Trigger Long-Term Distress
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Mammograms Can Measure How Breast Cancer Drug Is Working: Study
(Date:3/29/2017)... ... 29, 2017 , ... The Wharton School of the University of Pennsylvania is ... made a $10 million gift to establish the Ken Moelis and Julie Taffet ... to a Wharton MBA for highly-qualified Penn undergraduates whose academic and career interests expand ...
(Date:3/28/2017)... ... 2017 , ... Tuesday, March 28, 2017, is the annual American Diabetes Association ... Test to find out if they are at risk for developing Type 2 diabetes. ... evening sky by programming the LAX pylons the color red. Downtown’s U.S. Bank Tower ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, Inc., ... invited to the Siemens Healthineers annual customer education symposium, a world-class learning conference ... place from March 27 - 31, 2017 at the Atlanta Marriott Marquis in ...
(Date:3/28/2017)... ... March 28, 2017 , ... City trips ... (IBT World Travel Trends Report). As travelers visit both urban destinations, they are ... and prolonged sun exposure. In response, the outdoor industry has blurred the lines ...
(Date:3/28/2017)... ... ... Sentry Group LLC., a leader in the Personal Emergency Response System industry, introduced advanced ... These iSAFE products are the most affordable and most advanced medical alert systems on ... GPS Location and two-way calling with the push of a button on a nationwide ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... TORONTO , March 28, 2017 /PRNewswire/ - ... service medical device development firm, announced today that it ... Toronto -based medical device industrial design and productization ... companies throughout North America with ... device talent spanning the design, engineering, regulatory, and manufacturing ...
(Date:3/28/2017)... and TEL AVIV, Israel , March 28, 2017 ... Israel . This new business entity, Emosis Ltd, ... dedicated to research and development of novel assays complementing the mother ... when relevant, locally support commercialization and sales development of Emosis kits. ... This strategic move ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
Breaking Medicine Technology: